Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 1,440 | 1,643 | 1,583 | 1,109,186 | 1,639 |
| Cost of Goods | 131 | 148 | 187 | 136 | 149 |
| Gross Profit | 1,309 | 1,495 | 1,396 | 1,109,050 | 1,490 |
| Operating Expenses | 132,334 | 109,664 | 98,090 | 135,211 | 108,797 |
| Operating Income | -130,894 | -108,021 | -96,507 | 973,975 | -107,158 |
| Other Income | 723 | 776 | 743 | 920 | 1,423 |
| Pre-tax Income | -130,171 | -107,245 | -95,764 | 974,895 | -105,735 |
| Net Income Continuous | -130,171 | -107,245 | -95,764 | 974,895 | -105,735 |
| Net Income | $-130,171 | $-107,245 | $-95,764 | $974,895 | $-105,735 |
| EPS Basic Total Ops | -2.21 | -1.83 | -1.64 | 18.76 | -2.03 |
| EPS Basic Continuous Ops | -2.21 | -1.83 | -1.64 | 18.76 | -2.03 |
| EPS Diluted Total Ops | -2.21 | -1.83 | -1.64 | 18.53 | -2.03 |
| EPS Diluted Continuous Ops | -2.21 | -1.83 | -1.64 | 18.54 | -2.03 |
| EBITDA(a) | $-126,486 | $-103,765 | $-92,600 | $975,044 | $-106,184 |